SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-18-057858
Filing Date
2018-09-20
Accepted
2018-09-20 18:03:57
Documents
1
Period of Report
2018-09-20

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 6066
  Complete submission text file 0001104659-18-057858.txt   7407
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Issuer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address RUNGSTED STRANDVEJ 113 RUNGSTED KYST G7 2960
Business Address
Wedell-Wedellsborg Johan (Reporting) CIK: 0001753185 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38650 | Film No.: 181080224